Skip to main content

Table 1 Inclusion/exclusion criteria

From: Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial

Inclusion Criteria
•  Elective/subacute multivessel CABG
•  Isolated CABG procedure, no concomittant surgery
•  Age >18 years
•  Able to give informed consent
Exclusion Criteria
•  Myocardial infarction >48 h of surgery
•  Prior CABG surgery within one month
•  Cardiac Shock within 48 h of surgery
•  Atrial fibrillation
•  Anticoagulation therapy with VKA
•  ICH/TCI within 30 days
•  Prior peptic ulcer
•  Platelet count >150 E9
•  Ongoing bleeding
•  Known platelet disease
•  Allergic to aspirin or clopidogrel
•  Liver disease with elevated ALAT/ASAT >1.5x normal
•  Creatinine >0.120 mmol/l
•  Contrast allergy
•  Alcohol or narcotics abuse
•  Pregnancy
•  Geographically not available for follow-up
  1. This table shows the inclusion and exclusion criteria in the TEG-CABG trial